Press Releases

2009 Press Releases

Date		Title
December 17, 2009		SPECTRAL DIAGNOSTICS RAISES $14 MILLION AND ENTERS INTO STRATEGIC COLLABORATION WITH BIOMS MEDICAL TO COMMERCIALIZE TREATMENT FOR SEPSIS
December 17, 2009		BIOMS MEDICAL PROVIDES CORPORATE UPDATE
November 12, 2009		BioMS Medical Announces Third Quarter 2009 Results
September 2, 2009		BioMS Medical Provides Update on Dirucotide
July 27, 2009		Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial
July 17, 2009		BioMS Medical Announces Second Quarter 2009 Results
May 28, 2009		BioMS Medical to Present at the 2009 Symposium for the Canadian Society For Pharmaceutical Sciences
May 14, 2009		BioMS Medical to Participate in Panel Session at BIO International Convention 2009
May 11, 2009		BioMS Medical Announces First Quarter 2009 Results
April 29, 2009		BioMS Medical to Present at Alberta Economic Forum in Geneva
April 24, 2009		BioMS Medical to Present at BioFinance 2009
April 21, 2009		BioMS Medical’s Pivotal International Multiple Sclerosis Trial Receives Positive Review From Data Safety Monitoring Board
April 14, 2009		BioMS Medical’s Phase III U.S. Multiple Sclerosis Trial Receives Positive Safety Review From Data Safety Monitoring Board
March 17, 2009		BioMS Medical Announces 2008 Year End Results
March 2, 2009		BioMS Medical Warrant Extension
February 6, 2009		BioMS Medical to Participate in Bioindustry Session at BioPartnering North America
February 5, 2009		BioMS Medical to Present at BIO CEO and Investor Conference
January 30, 2009		BioMS Medical Reports Results of Exploratory Phase II Trial of Dirucotide in Relapsing-Remitting MS